Roanoke Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31,703
| Closed | -$1.3M | – | 98 |
|
|
2024
Q3 | $1.3M | Sell |
31,703
-640
| -2% | -$26.2K | 0.41% | 55 |
|
|
2024
Q2 | $1.25M | Sell |
32,343
-440
| -1% | -$16.9K | 0.41% | 55 |
|
|
2024
Q1 | $1.41M | Sell |
32,783
-244
| -0.7% | -$10.5K | 0.46% | 53 |
|
|
2023
Q4 | $1.22M | Buy |
33,027
+94
| +0.3% | +$3.48K | 0.45% | 54 |
|
|
2023
Q3 | $1.19M | Sell |
32,933
-1,711
| -5% | -$62K | 0.49% | 54 |
|
|
2023
Q2 | $1.24M | Sell |
34,644
-2,800
| -7% | -$99.8K | 0.49% | 56 |
|
|
2023
Q1 | $1.33M | Hold |
37,444
| – | – | 0.57% | 56 |
|
|
2022
Q4 | $1.32M | Sell |
37,444
-2,800
| -7% | -$98.4K | 0.6% | 54 |
|
|
2022
Q3 | $1.18M | Sell |
40,244
-180
| -0.4% | -$5.3K | 0.56% | 55 |
|
|
2022
Q2 | $2.2M | Buy |
40,424
+4,264
| +12% | +$232K | 0.99% | 37 |
|
|
2022
Q1 | $1.97M | Buy |
36,160
+800
| +2% | +$43.6K | 0.73% | 46 |
|
|
2021
Q4 | $1.95M | Buy |
35,360
+2,696
| +8% | +$149K | 0.65% | 45 |
|
|
2021
Q3 | $1.56M | Hold |
32,664
| – | – | 0.55% | 48 |
|
|
2021
Q2 | $1.63M | Buy |
32,664
+1,036
| +3% | +$51.6K | 0.56% | 47 |
|
|
2021
Q1 | $1.41M | Hold |
31,628
| – | – | 0.61% | 45 |
|
|
2020
Q4 | $1.46M | Sell |
31,628
-2,880
| -8% | -$132K | 0.69% | 44 |
|
|
2020
Q3 | $1.62M | Hold |
34,508
| – | – | 0.88% | 40 |
|
|
2020
Q2 | $1.76M | Buy |
34,508
+520
| +2% | +$26.5K | 1.02% | 34 |
|
|
2020
Q1 | $1.61M | Buy |
33,988
+336
| +1% | +$15.9K | 1.08% | 32 |
|
|
2019
Q4 | $1.98M | Buy |
33,652
+27,188
| +421% | +$1.6M | 0.99% | 38 |
|
|
2019
Q3 | $345K | Sell |
6,464
-960
| -13% | -$51.2K | 0.16% | 78 |
|
|
2019
Q2 | $371K | Buy |
7,424
+320
| +5% | +$16K | 0.17% | 78 |
|
|
2019
Q1 | $371K | Buy |
7,104
+344
| +5% | +$18K | 0.17% | 79 |
|
|
2018
Q4 | $323K | Buy |
+6,760
| New | +$323K | 0.17% | 80 |
|
|
2015
Q4 | – | Sell |
-16,120
| Closed | -$775K | – | 111 |
|
|
2015
Q3 | $775K | Buy |
16,120
+120
| +0.8% | +$5.77K | 0.28% | 72 |
|
|
2015
Q2 | $833K | Buy |
16,000
+2,040
| +15% | +$106K | 0.27% | 73 |
|
|
2015
Q1 | $805K | Buy |
13,960
+640
| +5% | +$36.9K | 0.26% | 74 |
|
|
2014
Q4 | $712K | Buy |
+13,320
| New | +$712K | 0.24% | 73 |
|